Daiwa Raises BEONE MEDICINES TP to USD476 as 3Q Again Beats Expectations and Guidance Raised

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Daiwa issued a research report stating that BEONE MEDICINES (06160.HK) +4.400 (+1.773%) Short selling $124.15M; Ratio 26.763% again delivered better-than-expected results in the third quarter and raised its full-year guidance. Revenue increased 34% YoY to USD1.89 billion, while product revenue rose 33% YoY to USD1.86 billion, exceeding both the broker's and market expectations, mainly driven by stronger-than-expected sales of Brukinsa. Adjusted non-GAAP net profit increased 77% YoY to USD539 million. Following the second quarter, the company again raised its FY2026 guidance, with revenue guidance lifted from USD6.6 billion-USD6.8 billion to USD6.9 billion-USD7 billion, while non-GAAP operating profit guidance was raised from USD1.7 billion-USD1.8 billion to USD1.9 billion-USD2 billion. The broker believes the revised targets are easily achievable.

The broker noted that global Brukinsa sales remained strong at USD1.4 billion, up 34% YoY and 11% QoQ, driven by continued growth in the US and European Union markets. US sales reached USD1 billion, up 36% YoY and 13% QoQ, including a positive contribution of about USD50 million from order timing. European Union sales rose 33% YoY and 11% QoQ to USD218 million. TEVIMBRA sales also beat expectations, reaching USD243 million, up 28% YoY. Research and development progress was encouraging, with multiple late-stage solid tumor assets advancing toward registration studies. The broker continues to view GPC3×4-1BB as a highly differentiated asset.

The broker reiterated its Buy rating on BeOne Medicines Ltd. (ONC.US) and, based on discounted cash flow valuation, raised its 12-month TP from USD450 to USD476. The broker also raised its 2026-2028 EPS forecasts by 1% to 15%, with its 2027-2028 forecasts standing 7% to 10% above market consensus.(ad/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-11-10 12:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

Source: AASTOCKS News The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.